Safety and efficacy of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia: A protocol for systematic review and meta-analysis

Safety and efficacy of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia: A protocol for systematic review and meta-analysis

<h3>Introduction</h3><p dir="ltr">Current evidence regarding the efficacy and safety of tyrosine kinase inhibitors in the pediatrics with chronic myeloid leukemia (CML) is limited. The safety of TKI beyond 15years of use has not been studied even in the adult population....

Full description

Saved in:
Bibliographic Details
Main Author: Fateen Ata (12217764) (author)
Other Authors: Rola S. Ghasoub (21322955) (author), Abdulqadir J. Nashwan (11659453) (author), Kamran Mushtaq (14150814) (author), Mahmood B. Aldapt (11255863) (author), Nancy A. Kassem (21322958) (author), Prem Chandra (9072038) (author), Nabil E. Omar (9545756) (author), Mohamed A. Yassin (8361183) (author)
Published: 2022
Subjects:
Biomedical and clinical sciences
Oncology and carcinogenesis
Paediatrics
Pharmacology and pharmaceutical sciences
chronic myeloid leukemia
pediatrics
preferred reporting Items for systematic reviews and meta-analyses
tyrosine kinase inhibitors
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items